Results 1 to 10 of about 38,428 (108)

Efficacy of Selective Internal Radiation Therapy for Hepatocellular Carcinoma Post-Incomplete Response to Chemoembolization [PDF]

Pharmaceuticals, 2023
Hepatocellular carcinoma (HCC) is one of the most common neoplasms worldwide and the third most common cause of cancer-related death. Several liver-targeted intra-arterial therapies are available for unresectable HCC, including selective internal ...
Salma Binzaqr, Frederic Debordeaux, Jean-Frédéric Blanc, Panteleimon Papadopoulos, Elif Hindie, Bruno Lapouyade, Jean-Baptiste Pinaquy   +6 more
doaj   +2 more sources

Clinically Translatable Phosphonated Silica Microspheres for Selective Internal Radiation Therapy of Hepatocellular Carcinoma [PDF]

Small Science, 2023
Selective internal radiation therapy (SIRT) is used as a locoregional therapy for hepatocellular carcinoma (HCC) to delay the progression of HCC. Thus far, various kinds of radioactive microspheres with different materials and radionuclides have been ...
Yi Zhou, Jianxian Ge, Yun Gao, Zhe Yang, Mohammad Javad Afshari, Can Chen, Manran Wu, Lei Chen, Shuwang Wu, Guangxin Duan, Jianfeng Zeng, Mingyuan Gao   +11 more
doaj   +2 more sources

Selective internal radiation therapy of metastatic breast cancer to the liver: A meta-analysis [PDF]

Frontiers in Oncology, 2022
IntroductionThe aim of this study is to conduct a meta-analysis to assess the efficacy of yttrium-90 selective internal radiation therapy (SIRT) in treating patients with breast cancer with hepatic metastasis.MethodPubMed and The Cochrane Library were ...
Chenyu Liu, George Tadros, Quinn Smith, Linda Martinez, James Jeffries, Zhiyong Yu, Qian Yu   +6 more
doaj   +2 more sources

A retrospective analysis of Selective Internal Radiation Therapy (SIRT) and chemotherapy for metastatic pancreatic adenocarcinoma [PDF]

BMC Cancer
Background Pancreatic ductal adenocarcinoma (PDAC) is a major cause of cancer-related deaths in Australia, with a 5-year survival rate of less than 13%. The liver is the most common site of PDAC metastasis, and is observed in over 50% of cases.
Sue S. Thang, Vijayaragavan Muralidharan, Manfred Spanger, Patrick Page, Adrian Fox, Sean Mackay, Lisa Miller, Raffiela Garcia, Ashleigh R. Poh, Caroline Le, Prasad Cooray   +10 more
doaj   +2 more sources

Adrenocortical carcinoma: selective internal radiation therapy and liver metastases [PDF]

Endocrine Oncology
Selective internal radiation therapy (SIRT) is a novel intervention for both primary and metastatic malignant liver lesions. Adrenocortical carcinoma (ACC) is rare with limited treatment options; evidence for SIRT in ACC liver metastases consists of case
Leo Baxendale-Smith, Karim El-Shakankery, James Gordon-Smith, Lucy Wall   +3 more
doaj   +2 more sources

Deep Learning-Based Auto-Segmentation for Liver Yttrium-90 Selective Internal Radiation Therapy [PDF]

Technology in Cancer Research & Treatment
The aim was to evaluate a deep learning-based auto-segmentation method for liver delineation in Y-90 selective internal radiation therapy (SIRT). A deep learning (DL)-based liver segmentation model using the U-Net3D architecture was built.
Jun Li PhD, Wookjin Choi PhD, Rani Anne MD   +2 more
doaj   +2 more sources

Research trends of selective internal radiation therapy for liver cancer: a bibliometric analysis [PDF]

Radiation Oncology
Background Liver cancer is a major contributor to cancer-related mortality. Selective internal radiation therapy (SIRT) for liver cancer has garnered increasing attention.
Mingkun Liu, Tong Xia, Qianqian Xu, Yanfeng Liu   +3 more
doaj   +2 more sources

Yttrium-90 selective internal radiation therapy for right hepatic malignancies: a clinical outcome study [PDF]

EJNMMI Research
Background Surgical resection offers long-term survival for liver malignancies, but insufficient future liver remnant (FLR) volume often precludes operability.
Xin Huang, Yong Liao, Ziwei Liang, Junpeng Ma, Bin Liang, Shizhong Yang, Guangxin Li, Tiantian Zhang, Linxia Zheng, Yafei Zhang, Mulan Tang, Bo Jia, Lin Zhang, Xiaobin Feng   +13 more
doaj   +2 more sources

Screening the advantageous population for liver cancer undergoing yttrium-90 microsphere selective internal radiation therapy [PDF]

Liver Research
Yttrium-90 microsphere selective internal radiation therapy (SIRT), also known as transarterial radioembolization, has become one of the pivotal treatments for liver cancer, particularly for selected advantageous patient groups.
Licong Liang, Yuchan Liang, Wensou Huang, Yongjian Guo, Jingjun Huang, Jingwen Zhou, Liteng Lin, Xinxin Nie, Mingyue Cai, Kangshun Zhu   +9 more
doaj   +2 more sources

Case Report: A case of delayed-onset benign distal esophageal stricture after Yttrium-90 microsphere selective internal radiation therapy [PDF]

Frontiers in Oncology
Yttrium-90 microsphere selective internal radiation therapy (Y90-SIRT) is a common local interventional treatment for hepatocellular Carcinoma and liver metastases. With the increasing use, extrahepatic complications have been gradually recognized.
Yang Gao, Yao Wei, Hengxiao Lu, Linlin Ji   +3 more
doaj   +2 more sources